Iclusig
Iclusig market is segmented by region (country), players, by Type and by Application. Players, st ... Read More
Global and United States Ponatinib Drugs Market Report & Forecast 2024-2031
1 Study Coverage
1.1 Ponatinib Drugs Product Introduction
1.2 Global Ponatinib Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Ponatinib Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Ponatinib Drugs Sales in Volume for the Year 2017-2028
1.3 United States Ponatinib Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Ponatinib Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Ponatinib Drugs Sales in Volume for the Year 2017-2028
1.4 Ponatinib Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Ponatinib Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Ponatinib Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Ponatinib Drugs Market Dynamics
1.5.1 Ponatinib Drugs Industry Trends
1.5.2 Ponatinib Drugs Market Drivers
1.5.3 Ponatinib Drugs Market Challenges
1.5.4 Ponatinib Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Ponatinib Drugs Market Segment by Type
2.1.1 45mg
2.1.2 15mg
2.2 Global Ponatinib Drugs Market Size by Type
2.2.1 Global Ponatinib Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Ponatinib Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Ponatinib Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Ponatinib Drugs Market Size by Type
2.3.1 United States Ponatinib Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Ponatinib Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Ponatinib Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Ponatinib Drugs Market Segment by Application
3.1.1 CML
3.1.2 ALL
3.2 Global Ponatinib Drugs Market Size by Application
3.2.1 Global Ponatinib Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Ponatinib Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Ponatinib Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Ponatinib Drugs Market Size by Application
3.3.1 United States Ponatinib Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Ponatinib Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Ponatinib Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Ponatinib Drugs Competitor Landscape by Company
4.1 Global Ponatinib Drugs Market Size by Company
4.1.1 Top Global Ponatinib Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Ponatinib Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Ponatinib Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Ponatinib Drugs Price by Manufacturer (2017-2022)
4.2 Global Ponatinib Drugs Concentration Ratio (CR)
4.2.1 Ponatinib Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Ponatinib Drugs in 2021
4.2.3 Global Ponatinib Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Ponatinib Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Ponatinib Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Ponatinib Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Ponatinib Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Ponatinib Drugs Market Size by Company
4.5.1 Top Ponatinib Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Ponatinib Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Ponatinib Drugs Sales by Players (2020, 2021 & 2022)
5 Global Ponatinib Drugs Market Size by Region
5.1 Global Ponatinib Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Ponatinib Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Ponatinib Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Ponatinib Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Ponatinib Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Ponatinib Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Ponatinib Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Ponatinib Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Ponatinib Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Ponatinib Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Ponatinib Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Ponatinib Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Ponatinib Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Ponatinib Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Ponatinib Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Ponatinib Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Ponatinib Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 ARIAD Pharmaceuticals
7.1.1 ARIAD Pharmaceuticals Corporation Information
7.1.2 ARIAD Pharmaceuticals Description and Business Overview
7.1.3 ARIAD Pharmaceuticals Ponatinib Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 ARIAD Pharmaceuticals Ponatinib Drugs Products Offered
7.1.5 ARIAD Pharmaceuticals Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Ponatinib Drugs Industry Chain Analysis
8.2 Ponatinib Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Ponatinib Drugs Distributors
8.3 Ponatinib Drugs Production Mode & Process
8.4 Ponatinib Drugs Sales and Marketing
8.4.1 Ponatinib Drugs Sales Channels
8.4.2 Ponatinib Drugs Distributors
8.5 Ponatinib Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Ponatinib Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Ponatinib Drugs Market Trends
Table 3. Ponatinib Drugs Market Drivers
Table 4. Ponatinib Drugs Market Challenges
Table 5. Ponatinib Drugs Market Restraints
Table 6. Global Ponatinib Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Ponatinib Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Ponatinib Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Ponatinib Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Ponatinib Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Ponatinib Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Ponatinib Drugs Revenue Share by Manufacturer, 2017-2022
Table 13. Global Ponatinib Drugs Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Ponatinib Drugs Sales Share by Manufacturer, 2017-2022
Table 15. Global Ponatinib Drugs Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Ponatinib Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Ponatinib Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ponatinib Drugs as of 2021)
Table 18. Top Players of Ponatinib Drugs in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Ponatinib Drugs Product Type
Table 20. Date of International Manufacturers Enter into Ponatinib Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Ponatinib Drugs Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Ponatinib Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Ponatinib Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Ponatinib Drugs Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Ponatinib Drugs Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Ponatinib Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Ponatinib Drugs Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Ponatinib Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Ponatinib Drugs Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Ponatinib Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Ponatinib Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Ponatinib Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Ponatinib Drugs Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Ponatinib Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Ponatinib Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Ponatinib Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Ponatinib Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Ponatinib Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Ponatinib Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Ponatinib Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. ARIAD Pharmaceuticals Corporation Information
Table 43. ARIAD Pharmaceuticals Description and Business Overview
Table 44. ARIAD Pharmaceuticals Ponatinib Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. ARIAD Pharmaceuticals Ponatinib Drugs Product
Table 46. ARIAD Pharmaceuticals Recent Development
Table 47. Key Raw Materials Lists
Table 48. Raw Materials Key Suppliers Lists
Table 49. Ponatinib Drugs Customers List
Table 50. Ponatinib Drugs Distributors List
Table 51. Research Programs/Design for This Report
Table 52. Key Data Information from Secondary Sources
Table 53. Key Data Information from Primary Sources
List of Figures
Figure 1. Ponatinib Drugs Product Picture
Figure 2. Global Ponatinib Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Ponatinib Drugs Market Size 2017-2028 (US$ Million)
Figure 4. Global Ponatinib Drugs Sales 2017-2028 (K Units)
Figure 5. United States Ponatinib Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Ponatinib Drugs Market Size 2017-2028 (US$ Million)
Figure 7. United States Ponatinib Drugs Sales 2017-2028 (K Units)
Figure 8. United States Ponatinib Drugs Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Ponatinib Drugs Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Ponatinib Drugs Report Years Considered
Figure 11. Product Picture of 45mg
Figure 12. Product Picture of 15mg
Figure 13. Global Ponatinib Drugs Market Share by Type in 2022 & 2028
Figure 14. Global Ponatinib Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Ponatinib Drugs Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Ponatinib Drugs Sales by Type (2017-2028) & (K Units)
Figure 17. Global Ponatinib Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Ponatinib Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 19. United States Ponatinib Drugs Market Share by Type in 2022 & 2028
Figure 20. United States Ponatinib Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States Ponatinib Drugs Sales Market Share in Value by Type (2017-2028)
Figure 22. United States Ponatinib Drugs Sales by Type (2017-2028) & (K Units)
Figure 23. United States Ponatinib Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States Ponatinib Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 25. Product Picture of CML
Figure 26. Product Picture of ALL
Figure 27. Global Ponatinib Drugs Market Share by Application in 2022 & 2028
Figure 28. Global Ponatinib Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 29. Global Ponatinib Drugs Sales Market Share in Value by Application (2017-2028)
Figure 30. Global Ponatinib Drugs Sales by Application (2017-2028) & (K Units)
Figure 31. Global Ponatinib Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 32. Global Ponatinib Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 33. United States Ponatinib Drugs Market Share by Application in 2022 & 2028
Figure 34. United States Ponatinib Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 35. United States Ponatinib Drugs Sales Market Share in Value by Application (2017-2028)
Figure 36. United States Ponatinib Drugs Sales by Application (2017-2028) & (K Units)
Figure 37. United States Ponatinib Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 38. United States Ponatinib Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 39. North America Ponatinib Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 40. North America Ponatinib Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 41. U.S. Ponatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 42. Canada Ponatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Europe Ponatinib Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 44. Europe Ponatinib Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 45. Germany Ponatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. France Ponatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. U.K. Ponatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. Italy Ponatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Russia Ponatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Asia-Pacific Ponatinib Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 51. Asia-Pacific Ponatinib Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 52. China Ponatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Japan Ponatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. South Korea Ponatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. India Ponatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Australia Ponatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Taiwan Ponatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Indonesia Ponatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Thailand Ponatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Malaysia Ponatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Philippines Ponatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Latin America Ponatinib Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 63. Latin America Ponatinib Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 64. Mexico Ponatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Brazil Ponatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Argentina Ponatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Middle East & Africa Ponatinib Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 68. Middle East & Africa Ponatinib Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 69. Turkey Ponatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Saudi Arabia Ponatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. UAE Ponatinib Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Ponatinib Drugs Value Chain
Figure 73. Ponatinib Drugs Production Process
Figure 74. Channels of Distribution
Figure 75. Distributors Profiles
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
ARIAD Pharmaceuticals